The Big Story

RFK further limits COVID-19 shot to high-risk groups

The U.S. Food and Drug Administration (FDA) approved updated versions of Pfizer and Moderna’s COVID-19 vaccines, but limited who is eligible to receive the shots.

© AP

Now, the jabs are approved for seniors and people with at least one underlying condition, putting them at a high risk of severe infection ahead of the upcoming respiratory viral season.

Moderna said the FDA greenlit its updated Spikevax vaccine, which offers protection against the LP.8.1 variant of the virus. Pfizer’s updated Comirnaty shot, which also provides protection against the variant, was approved by the agency, the company said in a statement.

Pfizer’s jab was approved for adults 65 and older, as well as people between ages 5 and 64 who have at

See Full Page